Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist
about
Androgen deprivation by activating the liver X receptor.Lipid metabolism emerges as a promising target for malignant glioma therapy.Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activationOn the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment.Inhibition Role of Atherogenic Diet on Ethyl Carbamate Induced Lung Tumorigenesis in C57BL/6J Mice.Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells.Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice.Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cellsLoss of stearoyl-CoA desaturase activity leads to free cholesterol synthesis through increased Xbp-1 splicing.Liver X receptor β activation induces pyroptosis of human and murine colon cancer cellsLack of liver X receptors leads to cell proliferation in a model of mouse dorsal prostate epithelial cell.Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.Minireview: nuclear receptor regulation of osteoclast and bone remodeling.Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cellsAndrogens as therapy for androgen receptor-positive castration-resistant prostate cancer.Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.Ligands of Therapeutic Utility for the Liver X Receptors.Anticancer activity of the cholesterol exporter ABCA1 gene.AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1/TSC2.Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signalingCholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cellsDistinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferationCaffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks.The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes.The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells.Negative regulation of Hedgehog signaling by liver X receptors.Liver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity.Orphan nuclear receptors as targets for drug development.NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder CancerDifferential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.Anticancer steroids: linking natural and semi-synthetic compounds.LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.Oxysterol receptors and their therapeutic applications in cancer conditions.Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.RORα inhibits adipocyte-conditioned medium-induced colorectal cancer cell proliferation and migration and chick embryo chorioallantoic membrane angiopoiesis.LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
P2860
Q30439040-FD9CEAE8-7165-4ABE-9B75-786AA8644303Q30684049-05DC462B-5C65-46DD-B328-CEF0E54EC732Q33637485-3EF2AD7C-F184-473B-AF73-E0981382AB16Q33737051-EE65D61D-0B9C-4DE2-9B69-07DAA60E5075Q33875922-7DCA1C30-2F50-4EF9-9A6F-8F13AAB18FC6Q33934005-7324B4E5-2A80-4A09-B347-838542333454Q34093125-E956512D-47A3-4D4B-B01D-D692E9C15C55Q34287799-0FD10CF2-816F-470D-8684-25805BBE75A4Q34306116-3F7730D0-F174-4BFC-871C-C9EE1966BA5AQ34425975-602B4EC2-3EBC-44BB-A7ED-3FB689C146FFQ34486432-7B63735A-1949-4AF0-8ECF-DAC993451995Q34648462-BCFF6357-EA3B-4900-B461-B18009C49543Q34722551-3D7D719E-9313-43F7-82F6-4F8DD735E8A8Q35054970-7D725BEF-3C3D-431A-8795-F7C9C817BD45Q35070404-E20E2ABF-4D9E-4904-90D8-7F322D4424D4Q35207110-E5E5DD36-ADEA-4DD4-A488-38B50127F83DQ35434843-0C7C6DE0-D2DC-4718-ADBD-51705B5D15A3Q35740051-BE325990-D56D-4620-8E37-525DBA423784Q36244293-83BDA7E8-F07C-438C-8FDE-0C2F258211E4Q36291341-134BC4E4-709A-4670-995B-2FBE7B0DA662Q36413704-BB844F47-DA59-4D43-B9BB-C9728C50B2DAQ36790229-AFECAA63-5A11-46ED-8875-ABD724F707E1Q36926791-60F4C142-F8D3-4924-8DE5-34C181B8F374Q37084995-7683B5EB-41D7-4DF8-B45F-37F8F55C4901Q37130094-A3C60E99-EC98-49B5-8BAD-C686D3FEC194Q37138526-EF4788B0-5B1C-4589-8606-5419975E95C4Q37219788-B20853CA-FC62-45F2-AAFE-124CE2D4E2B3Q37369781-95D011E7-7A19-4D6A-887A-FDFDF15DE334Q37597310-92B2CA3C-AD9B-4D45-81B5-E1002FBDFE5FQ37725708-E15D9773-BED6-408A-874C-A8FFF79AFAEFQ37738095-6DF3467F-1EEC-484F-A67B-2DC8B3BF87E2Q37741773-20AD82F5-2E2B-4955-9EED-718610E3B9E4Q38059807-A47CD895-F60D-4A0A-9A6D-E48DC6332786Q38077536-54EC9984-288E-4DEE-98B3-AFBD5655FC2BQ38123210-7132DADD-D371-4325-84D8-3C9E1039825CQ38256395-9B1EE6DF-62A1-47D8-942F-BBB66323F607Q38915850-58913172-08ED-4AFA-BAEF-CC4AEDA98C32Q38923071-69897172-DAE8-4814-9EEF-7C9512A86CB9Q38929341-405C7141-8044-4FEA-B233-0E07A074F90EQ39133022-45289B39-3099-42D4-942A-97C2C24CBB50
P2860
Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Inhibition of tumor growth and ...... n and liver X receptor agonist
@ast
Inhibition of tumor growth and ...... n and liver X receptor agonist
@en
Inhibition of tumor growth and ...... n and liver X receptor agonist
@nl
type
label
Inhibition of tumor growth and ...... n and liver X receptor agonist
@ast
Inhibition of tumor growth and ...... n and liver X receptor agonist
@en
Inhibition of tumor growth and ...... n and liver X receptor agonist
@nl
prefLabel
Inhibition of tumor growth and ...... n and liver X receptor agonist
@ast
Inhibition of tumor growth and ...... n and liver X receptor agonist
@en
Inhibition of tumor growth and ...... n and liver X receptor agonist
@nl
P2093
P3181
P1433
P1476
Inhibition of tumor growth and ...... n and liver X receptor agonist
@en
P2093
Chih-pin Chuu
John M Kokontis
Junichi Fukuchi
Richard A Hiipakka
Rou-Yu Chen
Shutsung Liao
P304
P3181
P356
10.1158/0008-5472.CAN-06-0632
P407
P577
2006-07-01T00:00:00Z